Findings

What do systematic reviews say?

13 questions · 13 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 23.1%Low 9 · 69.2%Moderate 1 · 7.7%High 0 · 0%

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

All symptomatic CMV disease · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 288 participants
Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

CMV organ involvement · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 217 participants
Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

Acute rejection · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 185 participants
Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

All‐cause mortality · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 176 participants
Low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

Graft loss · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 36 participants
Very low

Pre‐emptive medication for cytomegalovirus (CMV) viraemia vs placebo/no treatment

Leucopenia · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 114 participants
Low

Pre‐emptive medication vs prophylaxis

D+/R‐ serostatus: symptomatic CMV · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 39 participants
Very low

Pre‐emptive medication vs prophylaxis

D+ or D‐/R+ serostatus: symptomatic CMV · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 93 participants
Very low

Pre‐emptive medication vs prophylaxis

All symptomatic CMV disease · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 753 participants
Low

Pre‐emptive medication vs prophylaxis

Acute rejection · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 693 participants
Low

Pre‐emptive medication vs prophylaxis

Leucopenia · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 729 participants
Moderate

Pre‐emptive medication vs prophylaxis

All‐cause mortality · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 753 participants
Low

Pre‐emptive medication vs prophylaxis

Graft loss · solid organ transplant recipients with CMV viraemia

1 finding from 1 review

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant… 2013 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 753 participants
Low